Atropine and Omeprazole magnesium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atropine (atropine) and Omeprazole magnesium (omeprazole magnesium). Common drug interactions include creatinine renal clearance decreased among females and guillain-barre syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Atropine and Omeprazole magnesium. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Atropine?

Atropine has active ingredients of atropine. eHealthMe is studying from 8,693 Atropine users. Check the latest studies of Atropine.

What is Omeprazole magnesium?

Omeprazole magnesium has active ingredients of omeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 6,956 Omeprazole magnesium users. Check the latest studies of Omeprazole magnesium.



On Jul, 14, 2026

44 people who take Atropine and Omeprazole magnesium together, and have interactions are studied.

Atropine and Omeprazole magnesium drug interactions.

What are the common drug interactions of Atropine and Omeprazole Magnesium, by gender? *:

female:

  1. Creatinine renal clearance decreased
  2. Mobility decreased (ability to move is reduced)
  3. Pain
  4. Blood calcium decreased
  5. Hypotension (abnormally low blood pressure)
  6. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  7. Balance disorder
  8. Depressed level of consciousness
  9. Sedation
  10. Fall

male:

  1. Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
  2. Septic shock (shock due to blood infection)
  3. Fall
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. Hypertension (high blood pressure)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Renal failure chronic (long lasting kidney dysfunction)
  8. Subdural haematoma (blood collects between the skull and the surface of the brain)
  9. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

What are the common drug interactions of Atropine and Omeprazole Magnesium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal pain
  2. Anaemia (lack of blood)
  3. Anxiety
  4. Blood disorder
  5. Depression
  6. Diarrhoea
  7. Drug ineffective
  8. Drug intolerance (drug sensitivity)
  9. Dry eye (lack of adequate tears)
  10. Gastric disorder (disease of stomach)

60+:

  1. Constipation
  2. Creatinine renal clearance decreased
  3. Fall
  4. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  5. Dyspnoea (difficult or laboured respiration)
  6. Overdose
  7. Drug abuse
  8. Creatinine renal clearance increased
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

What are the existing conditions these people have? *

  1. Pain: 41 people, 93.18%
  2. High Blood Pressure: 39 people, 88.64%
  3. Urinary Tract Infection: 38 people, 86.36%
  4. Constipation: 38 people, 86.36%
  5. Fibromyalgia (a long-term condition which causes pain all over the body): 37 people, 84.09%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 37 people, 84.09%
  7. Chest Pain: 37 people, 84.09%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 37 people, 84.09%
  9. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 37 people, 84.09%
  10. Dementia (madness): 37 people, 84.09%

* Approximation only. Some reports may have incomplete information.

Do you take Atropine and Omeprazole magnesium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atropine and Omeprazole magnesium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atropine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Omeprazole magnesium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atropine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omeprazole magnesium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atropine and omeprazole magnesium (the active ingredients of Atropine and Omeprazole magnesium, respectively), and Atropine and Omeprazole magnesium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: